The impact of preoperative left atrial appendage thrombus on surgical outcomes in atrial fibrillation patients undergoing epicardial left atrial appendage closure - Report - MDSpire
Advertisement
The impact of preoperative left atrial appendage thrombus on surgical outcomes in atrial fibrillation patients undergoing epicardial left atrial appendage closure
Influence of Preoperative Left Atrial Appendage Thrombus on Surgical Results
Overview
This study investigates the impact of preoperative left atrial appendage (LAA) thrombus on outcomes in atrial fibrillation (AF) patients undergoing epicardial closure. The findings suggest that epicardial LAA closure is feasible and safe for patients with LAA thrombus, showing no significant increase in perioperative risks or long-term complications.
Background
Atrial fibrillation (AF) is a prevalent arrhythmia associated with a high risk of thromboembolic events, particularly strokes originating from the left atrial appendage (LAA). The presence of an LAA thrombus is traditionally a contraindication for epicardial left atrial appendage closure (LAAC), complicating treatment options for patients intolerant to anticoagulation. Understanding the safety and outcomes of LAAC in this patient population is crucial for optimizing stroke prevention strategies.
No intraoperative strokes or deaths occurred in either group.
Early postoperative complication rates were low and comparable between groups.
Thromboembolic event rates were similar between the No-Thrombus and Thrombus groups.
Thrombi confined to the LAA tip (Type I) were associated with favorable outcomes.
Epicardial LAAC is a viable option for patients with LAA thrombus who cannot tolerate anticoagulation.
Clinical Implications
Clinicians may consider epicardial LAAC as a safe alternative for stroke prevention in AF patients with LAA thrombus, particularly those at high risk for bleeding. Careful patient selection and imaging are essential to minimize perioperative risks.
Conclusion
Epicardial LAAC offers a promising approach for managing AF patients with LAA thrombus, ensuring safety and efficacy without increasing perioperative complications.
Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients